Improvements in the efficiency of gene targeting, by contrast, can be developed just as effectively in normal mice as in telomerase-negative ones.

• 相反，基因靶标有效性技术改善，在正常小鼠中和在负端粒酶小鼠中，可以被发展得一样有效。